Found: 28
Select item for more details and to access through your institution.
Editorial: Therapeutic potential of the cannabinoid CB2 receptor.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1039564
- By:
- Publication type:
- Article
Cannabinoid CB<sub>2</sub> Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer's Disease.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.841766
- By:
- Publication type:
- Article
Identifying opportunities for late-stage C-H alkylation with high-throughput experimentation and in silico reaction screening.
- Published in:
- Communications Chemistry, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42004-023-01047-5
- By:
- Publication type:
- Article
Prospective de novo drug design with deep interactome learning.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47613-w
- By:
- Publication type:
- Article
A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43606-3
- By:
- Publication type:
- Article
An Oxidation-Labile Traceless Linker for Solid-Phase Synthesis.
- Published in:
- Angewandte Chemie International Edition, 1999, v. 38, n. 8, p. 1073, doi. 10.1002/(SICI)1521-3773(19990419)38:8<1073::AID-ANIE1073>3.0.CO;2-Y
- By:
- Publication type:
- Article
NF‐κB activation in astrocytes drives a stage‐specific beneficial neuroimmunological response in ALS.
- Published in:
- EMBO Journal, 2018, v. 37, n. 16, p. 1, doi. 10.15252/embj.201798697
- By:
- Publication type:
- Article
Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)‐[<sup>11</sup>C]YH132: Application in Drug Development and Neurodegenerative Diseases.
- Published in:
- ChemBioChem, 2024, v. 25, n. 7, p. 1, doi. 10.1002/cbic.202300819
- By:
- Publication type:
- Article
Mutually Rewarding Academia‐Industry Collaborations in the Field of Chemical Biology.
- Published in:
- ChemBioChem, 2023, v. 24, n. 11, p. 1, doi. 10.1002/cbic.202300121
- By:
- Publication type:
- Article
EFMC: Trends in Medicinal Chemistry and Chemical Biology.
- Published in:
- ChemBioChem, 2023, v. 24, n. 7, p. 1, doi. 10.1002/cbic.202200690
- By:
- Publication type:
- Article
Highly Selective, Amine‐Derived Cannabinoid Receptor 2 Probes.
- Published in:
- Chemistry - A European Journal, 2020, v. 26, n. 6, p. 1380, doi. 10.1002/chem.201904584
- By:
- Publication type:
- Article
Cannabinoid CB<sub>2</sub> receptor ligand profiling reveals biased signalling and off-target activity.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 13958, doi. 10.1038/ncomms13958
- By:
- Publication type:
- Article
Multistep Solid-Phase Synthesis of an Antibiotic and Receptor Tyrosine Kinase Inhibitors Using the Traceless Phenylhydrazide Linker.
- Published in:
- Chemistry - A European Journal, 2003, v. 9, n. 14, p. 3282, doi. 10.1002/chem.200304821
- By:
- Publication type:
- Article
Development of the Traceless Phenylhydrazide Linker for Solid-Phase Synthesis.
- Published in:
- Chemistry - A European Journal, 2003, v. 9, n. 14, p. 3270, doi. 10.1002/chem.200304820
- By:
- Publication type:
- Article
An Enzyme-Labile Safety Catch Linker for Synthesis on a Soluble Polymeric Support.
- Published in:
- Chemistry - A European Journal, 2001, v. 7, n. 5, p. 959, doi. 10.1002/1521-3765(20010302)7:5<959::AID-CHEM959>3.0.CO;2-K
- By:
- Publication type:
- Article
Development of a membrane-based Gi-CASE biosensor assay for profiling compounds at cannabinoid receptors.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1158091
- By:
- Publication type:
- Article
A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature.
- Published in:
- PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0268590
- By:
- Publication type:
- Article
An Enzyme-Labile Safety Catch Linker for Combinatorial Synthesis on a Soluble Polymeric Support.
- Published in:
- Angewandte Chemie International Edition, 2000, v. 39, n. 9, p. 1629, doi. 10.1002/(SICI)1521-3773(20000502)39:9<1629::AID-ANIE1629>3.0.CO;2-E
- By:
- Publication type:
- Article
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced Uveitis.
- Published in:
- Molecules, 2019, v. 24, n. 18, p. 3338, doi. 10.3390/molecules24183338
- By:
- Publication type:
- Article
Reverse Design toward Optimized Labeled Chemical Probes - Examples from the Endocannabinoid System.
- Published in:
- Chimia, 2022, v. 76, n. 5, p. 425, doi. 10.2533/chimia.2022.425
- By:
- Publication type:
- Article
Late-Stage Functionalization and its Impact on Modern Drug Discovery.
- Published in:
- Chimia, 2022, v. 76, n. 3, p. 258, doi. 10.2533/chimia.2022.258
- By:
- Publication type:
- Article
Inside Cover: Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases (ChemMedChem 2/2016).
- Published in:
- ChemMedChem, 2016, v. 11, n. 2, p. 147, doi. 10.1002/cmdc.201500604
- By:
- Publication type:
- Article
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases.
- Published in:
- ChemMedChem, 2016, v. 11, n. 2, p. 179, doi. 10.1002/cmdc.201500218
- By:
- Publication type:
- Article
Comparative Molecular Profiling of the PPARα/γ Activator Aleglitazar: PPAR Selectivity, Activity and Interaction with Cofactors.
- Published in:
- ChemMedChem, 2012, v. 7, n. 6, p. 1101, doi. 10.1002/cmdc.201100598
- By:
- Publication type:
- Article
New Insights on the Mechanism of PPAR-targeted Drugs.
- Published in:
- ChemMedChem, 2010, v. 5, n. 12, p. 1973, doi. 10.1002/cmdc.201000446
- By:
- Publication type:
- Article
Design and Biological Evaluation of Novel, Balanced Dual PPARα/γ Agonists.
- Published in:
- ChemMedChem, 2009, v. 4, n. 6, p. 951, doi. 10.1002/cmdc.200800425
- By:
- Publication type:
- Article
Inside Cover: Design and Biological Evaluation of Novel, Balanced Dual PPARα/γ Agonists (ChemMedChem 6/2009).
- Published in:
- ChemMedChem, 2009, v. 4, n. 6, p. 886, doi. 10.1002/cmdc.200990027
- By:
- Publication type:
- Article
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1426446
- By:
- Publication type:
- Article